Our previous finding that the tumor suppressor p53 is covalently linked to 5.8S rRNA suggested functional association of p53 polypeptide with ribosomes. p53 polypeptide is expressed at low basal levels in the cytoplasm of normal growing cells in the G 1 phase of the cell cycle. We report here that cytoplasmic wild-type p53 polypeptide from both rat embryo fibroblasts and MCF7 cells and the A135V transforming mutant p53 polypeptide were found associated with ribosomes to various extents. Treatment of cytoplasmic extracts with RNase or puromycin in the presence of high salt, both of which are known to disrupt ribosomal function, dissociated p53 polypeptide from the ribosomes. In immunoprecipitates of p53 polypeptide-associated ribosomes, 5.8S rRNA was detectable only after proteinase K treatment, indicating all of the 5.8S rRNA in p53-associated ribosomes is covalently linked to protein. While 5.8S rRNA linked to protein was found in the immunoprecipitates of either wild-type or A135V mutant p53 polypeptide associated with ribosomes, little 5.8S rRNA was found in the immunoprecipitates of the slowly sedimenting p53 polypeptide, which was not associated with ribosomes. In contrast, 5.8S rRNA was liberated from bulk ribosomes by 1% sodium dodecyl sulfate, without digestion with proteinase K, indicating that these ribosomes contain 5.8S rRNA, which is not linked to protein. Immunoprecipitation of p53 polypeptide coprecipitated a small fraction of ribosomes. p53 mRNA immunoprecipitated with cytoplasmic p53 polypeptide, while GAPDH mRNA did not. These results show that cytoplasmic p53 polypeptide is associated with a subset of ribosomes, having covalently modified 5.8S rRNA.
The tumor suppressor p53 is found expressed at low basal levels in the cytoplasm of normal growing cells in the G 1 phase of the cell cycle (50) . DNA-damaging agents cause its rapid induction and translocation to the nucleus (17, 25, 29, 33) . More recently, other stresses have been found to induce p53 (19) . Induction of nuclear p53 causes G 1 arrest (25, 30) or apoptosis (40a) . The inability to induce functional p53 results in chromosomal abnormalities, characteristic of tumor progression, presumably through failure to delay the cell cycle in G 1 and hence to repair DNA damage before replication (21) . Control of the intracellular concentration of p53 has been shown to be exerted at the levels of transcription and protein turnover, and there is accumulating evidence of control at the level of translation. p53 mRNA levels do not change upon induction of the protein by DNA damage, indicating posttranscriptional control (25, 28) ; actinomycin D, which is a transcriptional inhibitor as well as a DNA-damaging agent, induces p53, indicating that transcription is not necessary for the induction. The translational inhibitor cycloheximide inhibits the induction (25) . Furthermore, ionizing radiation induces p53 within 10 min, which is too rapid for transcription, splicing, transport of mRNA, and translation to occur (24a) . Overexpressed mutant p53 polypeptide is not further induced by DNA damage (17, 25) , which may suggest that the wild-type (wt) p53 polypeptide has a negative autoregulatory role in the translation of its own mRNA. Like the induction of the stress proteins, Hsp70 after heat shock and GCN4 after amino acid starvation (32, 54) , p53 induction by DNA damage occurs in the face of general down-regulation of bulk protein synthesis (17) , indicating that p53 translation is controlled differently than translation of bulk mRNA.
The functions of p53 polypeptide correlate with specific domains. The amino-terminal region is the transcriptional transactivation domain, and it interacts with some components of the basal transcriptional machinery (14, 31, 43, 46) . The central domain contains the majority of mutations found in tumors (41) and has been shown to contact DNA at consensus sites (2, 7, 44, 57) . The carboxy terminus of the molecule contains the nuclear localization and oligomerization sequences (24, 44, 51, 52) . It is also involved in (i) regulating the specific DNA binding activity of the central domain (3) , (ii) RNA binding, and (iii) annealing of complementary single strands of RNA or DNA (42, 58) . Furthermore, we have previously reported that p53 polypeptide is covalently linked to RNA at a specific serine residue (47, 48) .
We identified the RNA covalently linked to p53 polypeptide as 5.8S rRNA (15) . Subsequently, Marechal et al. (34) identified a ribonucleoprotein complex composed of 5S rRNA, L5 ribosomal protein, mdm-2 protein, and p53 polypeptide covalently linked to 5.8S rRNA. Furthermore, it has been previously shown that L5 ribosomal protein, 5S rRNA, and 5.8S rRNA form a ternary complex in solution (36) . The occurrence of these complexes suggests that p53 polypeptide may be involved in one or more of the following mechanisms: (i) regulation of the transcription of rRNA genes; (ii) processing of rRNA precursors; (iii) transport of ribosomes from the nucleus to the cytoplasm; and (iv) translational control, in which case we postulated it would be bound to ribosomes.
Our previous findings that p53 polypeptide is covalently linked to 5.8S rRNA and that p53 polypeptide sedimented in a sucrose gradient with an S value higher than that expected for the 8S tetramer suggested association of p53 polypeptide with ribosomes (15) . We report here that cytoplasmic wt p53 polypeptide cosedimented to various degrees with ribosomes, while mutant p53 was only partially associated. Agents such as RNase A or puromycin in high salt, which affect the integrity of monosomes and polysomes, shifted p53 polypeptide to a slowly sedimenting form. p53 polypeptide covalently linked to 5.8S rRNA was found to associate with only a small fraction of ribosomes. In addition, p53 mRNA specifically coimmunoprecipitated with p53 polypeptide.
MATERIALS AND METHODS
Cells and cell lines. The cell line clone 2 was derived by Michalovitz et al. (38) from rat embryo cells by transfection with ras and the Ala135Val mutant of mouse p53. Primary rat embryo fibroblasts (REF) were obtained from Fisher. MCF7, which is a human breast adenocarcinoma cell line but expresses wild-type p53, was obtained from the American Type Culture Collection.
Preparation, treatment, and rate zonal centrifugation of cytoplasmic extracts. Ten tissue culture dishes (100 by 20 mm) of subconfluent (ϳ70%) REF and MCF7 cells were starved for 30 min in a methionine-free medium containing 5% dialyzed calf serum at 37°C and then labeled with 5 mCi of [
35 S]methionine for 2 h at 37°C. Six tissue culture dishes (100 by 20 mm) of subconfluent (ϳ70%) clone 2 cells were either labeled overnight or starved as described above, labeled with 5 mCi of [
35 S]methionine for 2 h at 37°C, and chased overnight. Cytoplasmic extracts were prepared by a modification of the method of Greenberg and Ziff (20) , with the addition of 400 U of RNasin per ml, 2 mM dithiothreitol, 40 g of aprotinin per ml, 0.4 mg of leupeptin per ml, 100 g of cycloheximide per ml, and 0.15 mg of phenylmethylsulfonyl fluoride per ml to the Nonidet P-40 lysis buffer. Nuclei were centrifuged from the extract by centrifugation at 500 ϫ g for 5 min at 4°C. Cytoplasmic extracts were applied to 20 to 60% sucrose gradients. The centrifugation buffer used in the gradients throughout was 50 mM Tris-HCl (pH 7.4)-50 mM KCl-2.5 mM MgCl 2 except for the gradients used for treatment with 400 mM KCl or 400 mM KCl with puromycin. Gradients (12 ml) were collected, through an ISCO UV monitor reading 254 nm, into 0.5-ml fractions. Centrifugation was performed at 35,000 rpm at 4°C for 3 h 15 min in a Beckman SW41 rotor. RNase treatment of cytoplasmic extracts was carried out with 12.5 g of DNase-free RNase A per ml at 4°C for 15 min. After this treatment, the extracts were loaded on 20 to 60% sucrose gradients as described above. Before treatment of the cytoplasmic extracts with either high salt alone or high salt with puromycin, the concentration of MgCl 2 in the extract was raised to 5 mM. High-salt treatment was performed with 400 mM KCl followed by incubation at room temperature for 15 min. Puromycin treatment was carried out with the addition of puromycin and KCl (final concentrations of 5 and 400 mM, respectively) to the cytoplasmic extract followed by incubation at room temperature for 15 min. The puromycin-treated extracts were then applied to 12-ml 10 to 50% sucrose gradients containing the same salt concentration as used for the sample treatment. Gradient centrifugation was performed for 2 h.
Immunoprecipitation and detection of p53 polypeptide. p53 polypeptide was immunoprecipitated from 0.5-ml gradient fractions as described previously (15) . Two negative control sera were used: normal mouse serum and the irrelevant murine monoclonal antibody PAb101 (simian virus 40 T-antigen specific). The murine monoclonal antibodies specific for p53 used included PAb240, PAb242, PAb248, PAb122, PAb421, and DO1. Prior to immunoprecipitation of cytoplasmic extracts for the purpose of preparing 18S and 28S rRNAs from p53-bound ribosomes, extracts were preabsorbed with PAb101 bound to protein A-Sepharose. Serial immunoprecipitation was performed as previously reported (6) . Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (10% polyacrylamide gel) and fluorography were carried out as described previously (15) .
Detection of rRNAs, p53 mRNA, and GAPDH mRNA. The 5.8S rRNA covalently linked to p53 was prepared as follows. Clone 2 or MCF7 cells were labeled with 32 P i (300 Ci/ml) for 6 h in Dulbecco's modified Eagle's medium containing 10% of the normal concentration of phosphate and 10% dialyzed fetal calf serum. Cytoplasmic extracts, gradient conditions, fractionation, and immunoprecipitation of the gradient fractions were performed as described above. However, the immunoprecipitates were eluted with 2ϫ proteinase K buffer (0.2 M Tris-HCl [pH 7.5], 2% SDS, 25 mM EDTA, 0.3 M NaCl, with the addition of 10 mM vanadyl ribonucleoside complex) for 15 min at 37°C. Samples were diluted 1:2 with H 2 O and digested with 200 g of fresh proteinase K per ml for 1 h at 37°C. RNA was then prepared by phenol-chloroform extraction and ethanol precipitation (49) in the presence of 20 to 40 g of carrier glycogen per ml. Seven molar urea-PAGE was performed as previously described (15) .
In the serial immunoprecipitation experiment, the final supernatant was subjected to poly(A) selection. RNAs were subjected to electrophoresis in 1% agarose gels containing formaldehyde and visualized by autoradiography or by staining with ethidium bromide (49) .
The Northern blots of immunoprecipitated RNAs after agarose gel electrophoresis were hybridized (49) with radiolabeled probes against p53 or GAPDH mRNA. The p53 coding region probe was obtained by digesting plasmid p11-4 (53) with StuI and EcoRV. The GAPDH probe was provided by D. E. Levy. The human p53 coding region probe was provided by M. Kastan.
RESULTS

Association of cytoplasmic p53 polypeptide with ribosomes.
The predicted cosedimentation of p53 polypeptide with ribosomes and the effect of a p53 mutation on this cosedimentation were first examined. To avoid disassembly of polysomes, which might happen during the early steps in cell fractionation, cells were fractionated immediately upon harvest in the presence of cycloheximide to freeze ribosomes on the mRNAs. Cytoplasmic fractions were used throughout to eliminate consideration of association of p53 polypeptide with nuclear substituents.
In Fig. 1 , 40S and 60S ribosomal subunits, 80S monosomes, and polysomes were resolved by sucrose gradient centrifugation. Immunoprecipitation of [ 35 S]Met-labeled proteins from gradient fractions specifically precipitated wt p53 polypeptide from both primary REF (Fig. 1B ) and MCF7 cells (Fig. 1D ) and A135V mutant p53 polypeptide from clone 2 cells ( Fig. 1F and G), which were derived from REF by transfection with ras and the A135V temperature-sensitive mutant of mouse p53 (38) . Clone 2 cells overexpress cytoplasmic mutant p53 at 37.5°C, which has an extended half-life. The specifically immunoprecipitated material was confirmed to be p53 polypeptide on the basis of electrophoretic mobility, reactivity with p53-specific monoclonal antibodies, and tryptic fingerprinting as previously reported (47) . Nearly all of wild-type p53 polypeptide from REF, part of the wt p53 polypeptide from the MCF7 cells, and the A135V mutant p53 polypeptide cosedimented with ribosomes. The observed heterogeneous sedimentation rate of Ն80S of cytoplasmic wt p53 polypeptide is greater than that expected for the 8S tetramer of p53 alone, suggesting association of p53 polypeptide with ribosomes. However, the distribution of wt p53 polypeptide even from REF was not precisely that of total ribosomes. This result suggested association of p53 polypeptide with only a subset of ribosomes, as will be addressed later. In contrast to the sedimentation of wt p53 polypeptide from REF, the wt p53 polypeptide from MCF7 cells, and to an even greater extent, A135V mutant p53 polypeptide was found mostly at the top of the gradient in fractions 1 to 4, not associated with ribosomes. However at least 20% of the mutant p53 (estimated by densitometry) cosedimented with ribosomes (fractions 6 with monosomes, 7 to 10 with small polysomes, and 11 to 19 with large polysomes). Consequently, because the mutant p53 is overexpressed and has an extended half-life and therefore there is more total p53 in clone 2 cells, p53-bound ribosomes are more abundant in clone 2 cells than in REF or MCF7 cells, even though a smaller percentage of the mutant p53 is bound to ribosomes. The altered sedimentation of mutant p53 could have been due to (i) overexpression of p53 polypeptide to such an extent that it would be in excess of its potential binding sites on ribosomes; (ii) a decrease in the affinity of mutant p53 polypeptide for the ribosomes; or (iii) the fact that less of the mutant p53 polypeptide is linked to 5.8S rRNA, which may be necessary for binding to ribosomes (addressed below). It should also be mentioned that clone 2 cells contain endogenous rat wt p53 that can be seen as a band above the overexpressed exogenous mouse p53 polypeptide (Fig. 2C) . The A135V mutant p53 is a dominant negative mutant polypeptide, and therefore it binds the wt protein and inactivates it (12) .
The same high-affinity monoclonal antibody, PAb248, was used to compare the sedimentations of wt (REF) and A135V mutant (clone 2) p53 polypeptides ( Fig. 1B and F) . Immunoprecipitation of A135V mutant p53 with the C-terminal-specific monoclonal antibody PAb122 gave the same result as immunoprecipitation with PAb248 (Fig. 1G ). When A135V mutant p53 was radiolabeled with a 2-h pulse, rather than a pulse followed by a chase in unlabeled medium, the profile of radiolabeled p53 (data not shown) was the same as that shown in Fig. 1F . This result indicated that the difference observed between wt and mutant was not the result of difference in conditions of radiolabeling.
p53 polypeptide cosedimented with ribosomes because it was bound to ribosomes. It did not merely cosediment in another large, heterogeneous complex, because immunoprecipitation of p53 polypeptide from cytoplasmic extracts specifically coprecipitated rRNAs, as demonstrated below. While it is possible to immunoprecipitate polysomes by using antibodies against individual nascent proteins, this possibility was excluded, because the p53 polypeptide associated with the ribosomes was full sized. In addition, the mutant p53 polypeptide from clone 2 cells, which has a long half-life, was labeled with a 2-h pulse and was still found associated with ribosomes after an 18-h chase in unlabeled medium (Fig. 1G) . Because of the short half-life of wt p53 polypeptide, this pulse-chase experiment could not be performed with wt p53 polypeptide. The monoclonal antibody PAb122, which recognizes a carboxylterminal epitope of p53 polypeptide, immunoprecipitated p53 polypeptide associated with ribosomes, also indicating the p53 polypeptide is not nascent (Fig. 1G) . These results demonstrate that full-sized, mature p53 polypeptide associates with ribosomes.
Dissociation of p53 polypeptide from ribosomes by RNase digestion or by puromycin in high-salt buffer. To further establish that the cosedimentation of p53 polypeptide with ribosomes indicated association, cytoplasmic extracts were treated with agents known to disrupt ribosomal function. Cytoplasmic extracts of REF, MCF7 cells, and clone 2 cells were treated with RNase A and analyzed in the same manner as for Fig. 1 , by fractionation, centrifugation for 3.25 h, and immunoprecipitation (Fig. 2) . As expected, due to degradation of mRNAs, polysomes were converted to monosomes by RNase treatment (Fig. 2, top panels) . Most of the wt p53 polypeptide was converted to a slowly sedimenting form at the top of the gradient ( Fig. 2A and B , bottom panels). However, a small but detect- 35 S]methionine for 2 h at 37°C as described in Materials and Methods. Cytoplasmic extracts were loaded on 20 to 60% sucrose gradients and centrifuged, and the gradient fractions were collected as described in Materials and Methods. Immunoprecipitation of the fractions was performed, alternatively, with PAb248 (even-numbered lanes) or negative control serum (odd-numbered lanes) for REF (B) . For MCF7 cells (D), DO1 (even-numbered lanes) and negative control PAb101 (odd-numbered lanes) were used. Clone 2 cells were radiolabeled overnight with [ 35 S]methionine (F), or the cells were first starved for 30 min, radiolabeled with [
35 S]methionine for 2 h at 37°C, and chased overnight (G). Cytoplasmic extracts were prepared and loaded on sucrose gradients as described above. Immunoprecipitations were performed as follows: (F) negative control serum (even-numbered lanes) or PAb248 (odd-numbered lanes); (G) PAb122 (even-numbered lanes) or negative control serum (odd-numbered lanes). SDS-PAGE and fluorography were performed. Monomer indicates monosome or monomeric ribosomes. able amount of the wt p53 polypeptide remained associated with monosomes (see Discussion). All of the detectable A135V mutant p53 polypeptide was shifted to the top of the gradient (Fig. 2C, bottom panel) .
Radiolabeled cytoplasmic extracts of MCF7 and clone 2 cells were treated either with the translation inhibitor puromycin in the presence of high-salt buffer or with high-salt buffer alone. Treatment with puromycin in high-salt buffer causes the dissociation of ribosomal subunits. After performance of this treatment with cytoplasmic extracts of MCF7 and clone 2 cells, the extracts were applied to sucrose gradients and centrifuged for 2 h, and the optical density at 254 nm (OD 254 ) profile was determined as described in Materials and Methods (Fig. 3, top  panels) . While the treatment with 0.4 M KCl alone did cause some dissociation of polysomes ( Fig. 3A and B) , the treatment with puromycin in 0.4 M KCl caused maximal dissociation of polysomes and dissociation of all p53 from ribosomes. Most, if not all, of the wt and mutant p53 polypeptides were shifted after treatment with puromycin and high salt to a slowly sedimenting form (Fig. 3C and D, bottom panels) . Because wt p53 polypeptide was dissociated from the ribosomes by treatment with puromycin (contrast Fig. 3A and C) , it is apparent that p53 polypeptide is associated with the translation machinery. Dissociation of Hsp70 from polysomes by treatment with RNase or puromycin has been used to argue for the functional association of Hsp70 with polysomes (40) . By the same token, the cosedimentation of p53 polypeptide with ribosomes and the dissociation of p53 polypeptide from ribosomes, which is caused by treatments with RNase and with puromycin in high salt, suggest that p53 polypeptide is functionally associated with ribosomes.
Association of p53 polypeptide with rRNAs. Biochemical analysis of RNAs present in p53 polypeptide-associated ribosomes was carried out with MCF7 and clone 2 cells, which have significant and easily detectable amounts of p53 polypeptide associated with ribosomes. We found we could not use REF because they express levels of p53 polypeptide too low for these analyses. Use of the mutant p53 polypeptide for these studies is valid, because we have previously shown that A135V p53 polypeptide, like the wt polypeptide is covalently linked to 5.8S rRNA (15) . In Fig. 4 , clone 2 cells were labeled with [ 32 P]orthophosphate, and cytoplasmic extracts were analyzed by centrifugation, immunoprecipitation, and SDS-PAGE as in Fig. 1 . The A135V mutant p53 polypeptide was detected sedimenting with ribosomes and polysomes after radiolabeling with [ 32 P]orthophosphate (Fig. 4A) . Figure 4B shows the result of treatment of the cytoplasmic extract with RNase A prior to sedimentation and immunoprecipitation as in Fig. 2 . Phosphorylated p53 polypeptide was converted to a slowly sedimenting form found at the top of the gradient. In addition, a marked decrease in the amount of 32 P recovered in the band was observed. This result would be consistent with loss of part or all of the 5.8S rRNA linked to p53 polypeptide. When cytoplasmic extracts of clone 2 cells were centrifuged for longer times, the A135V mutant polypeptide present at the top of the gradient sedimented more slowly than 40 and 60S ribosomal subunits (data not shown).
We also determined the distribution in the polysome profile of 5.8S rRNA covalently linked to mutant p53 polypeptide. Clone 2 cells (Fig. 4C and D ) and MCF7 cells (Fig. 4E and F) were radiolabeled with [ 32 P]orthophosphate, and the cytoplasmic extracts were loaded onto a sucrose gradient as described for Fig. 1 . The fractions were immunoprecipitated with either nonimmune serum or a monoclonal antibody that recognizes p53 polypeptide. In Fig. 4C and E, the immunoprecipitates were treated with proteinase K buffer (containing SDS) but without proteinase K and were then phenol-chloroform extracted, ethanol precipitated, and resolved by 7 M urea-PAGE. After these denaturing procedures, no RNA band was detected in the position of 5.8S rRNA. However, when the immunoprecipitates were treated identically except digested with proteinase K, 5.8S rRNA could be observed in the specifically immunoprecipitated fractions (Fig. 4D and F) . This result showed that the 5.8S rRNA in the p53-associated ribosomes was entirely covalently linked to protein in both cell lines. We assume that it is lost in the phenol-chloroform layer when the fractions are not treated with proteinase K. The identity of the 5.8S rRNA was confirmed by hybridization of the RNA to the radiolabeled 5.8S cDNA probe, as we previously reported (reference 15 and data not shown). We have also observed that 5.8S rRNA can be liberated from SDS-PAGE bands of specifically immunoprecipitated p53 polypeptide by treatment with proteinase K, as previously described (15) . In addition, the p53 polypeptide-5.8S rRNA complex was found almost entirely in the monosome-polysome region of the gradient, not in the fractions of A135V p53 polypeptide not associated with ribosomes and sedimenting at the top of the gradient. In marked contrast, 5.8S rRNA was easily extracted under denaturing conditions from bulk, unfractionated ribosomes, without the necessity of proteinase K digestion (Fig. 4H) . In Fig. 4H , unfractionated [ VOL. 17, 1997 ASSOCIATION OF CYTOPLASMIC p53 WITH RIBOSOMES 3149
on June 22, 2017 by guest http://mcb.asm.org/ ethanol precipitation, was resolved by 7 M urea-PAGE. This result shows that there is a population of 5.8S rRNA that was observed without proteinase K treatment and therefore that the 5.8S rRNA in these bulk ribosomes is not covalently linked to p53. p53 polypeptide, which was immunoprecipitated from cytoplasmic extracts of clone 2 cells, specifically coprecipitated 18S and 28S rRNAs (Fig. 4G) . Five different p53-specific monoclonal antibodies against a variety of epitopes immunoprecipitated p53-bound ribosomes, while normal mouse serum and an irrelevant simian virus 40 T-antigen-specific antibody, PAb101, did not. This result demonstrates that not only does a portion of p53 polypeptide cosediment with ribosomes ( Fig. 1F and G) , but it is in fact bound to ribosomes, thereby causing coprecipitation of rRNAs. When rRNA was prepared after a serial immunoprecipitation of p53 polypeptide from clone 2 cells, no more than 4% of 18S and 28S rRNAs was coprecipitated (data not shown). This result indicates that p53 polypeptide was associated with only a small fraction of ribosomes, even in cells overexpressing p53 polypeptide.
In summary, we have shown that there is a small fraction of ribosomes in which 5.8S rRNA is covalently linked to p53 polypeptide, while in marked contrast, the major population of ribosomes is not associated with p53 polypeptide. polypeptide, which is not associated with ribosomes, is not linked to 5.8S rRNA, while the equivalent fraction of wt p53 polypeptide from MCF7 cells may have some linked 5.8S rRNA. This result suggests linkage of p53 to 5.8S rRNA contributes to the ability of full-sized p53 polypeptide to associate with ribosomes. In addition, these results further show that the p53 polypeptide associated with ribosomes is not nascent, because it is covalently linked to 5.8S rRNA, and as we have previously shown, this linkage is to the penultimate amino acid (47, 48) .
Coimmunoprecipitation of p53 mRNA with ribosomes bound to the p53 polypeptide. Taken together, these findings suggest that if cytoplasmic p53 functions on the polysomes, it does so to affect translation of a small subset of mRNA. We suspected that the mRNA associated with p53 polypeptide might be p53 mRNA because (i) p53 mRNA itself has the hallmarks of a translationally regulated mRNA (4, 5); (ii) mutant p53 is overproduced and cannot be further induced by DNA damage, suggesting that wt p53 polypeptide controls its own synthesis (17, 25) ; and (iii) the induction of p53 by DNA damage is posttranscriptional and inhibited by cycloheximide (25) , suggesting that induction may be, at least in part, translational. To determine whether ribosome-associated p53 polypeptide is associated with its own mRNA, RNA was prepared from serial immunoprecipitates of cytoplasmic extracts containing p53 polypeptide and from the final supernatant depleted of p53 polypeptide (Fig. 5) . The RNA was resolved by electrophoresis and then transferred to nitrocellulose and probed for p53 and GAPDH mRNAs. Immunoprecipitation of p53 polypeptide from extracts of clone 2 cells coprecipitated p53 mRNA (Fig. 5A, lanes 1 to 3) . Poly(A) ϩ p53 mRNA was also detectable in the supernatant depleted of p53 polypeptide (Fig. 5A, lane S) . Since these cells contain endogenous rat p53 mRNA with a wt 5Ј untranslated region (5Ј UTR) and exogenous mouse p53 mRNA without a 5Ј UTR, both of which are recognized by the probe, these two p53 mRNAs may be differently recognized by p53 polypeptide-bound ribosomes. The membrane was then stripped and reprobed with a GAPDH probe (Fig. 5B) . No GAPDH mRNA was detected in the immunoprecipitates, indicating that p53 polypeptide binds specifically to ribosomes bearing p53 mRNA and/or directly to p53 mRNA.
DISCUSSION
We report here three novel findings: (i) cytoplasmic p53 polypeptide is associated with a small fraction of ribosomes; (ii) the 5.8S rRNA, which is in this subset of ribosomes, is covalently linked to protein; and (iii) p53 mRNA coprecipitates with the p53 polypeptide. 32 P]orthophosphate as described in Materials and Methods. (A) Cytoplasmic extracts of clone 2 cells were fractionated and loaded in a 20 to 60% sucrose gradient. Centrifugation and immunoprecipitation, with either PAb248 or negative control serum, were performed as described for Fig. 1. (B) The experiment was performed as for panel A except that the cytoplasmic extract was treated with RNase as for Fig. 3. (C to F) Immunoprecipitates of gradient fractions were prepared from clone 2 or MCF7 cells as for panel A, and then RNA was prepared from the immunoprecipitates without or with proteinase K treatment as described in Materials and Methods and resolved by 7 M urea-PAGE. (C) Clone 2, no proteinase K; (D) clone 2, with proteinase K; (E) MCF7, no proteinase K; (F) MCF7, with proteinase K. The position of the 5.8S marker is indicated. (G) A cytoplasmic extract of clone 2 cells, which was preabsorbed with the negative control PAb101, was subjected to immunoprecipitation as described in Materials and Methods, using normal mouse serum (NMS) or PAb101 as a negative control or with the indicated p53-specific monoclonal antibodies. RNA was prepared from the immunoprecipitates, and the 18S and 28S rRNAs were resolved by agarose gel electrophoresis and observed by autoradiography as described in Materials and Methods. (H) RNA was prepared from unfractionated cytoplasmic extract of clone 2 cells as described in Materials and Methods except that proteinase K treatment was not performed. The positions of the RNAs are indicated.
The cytoplasmic p53 polypeptide associated with ribosomes was mature, not nascent, polypeptide because it was (i) full sized by SDS-PAGE ( Fig. 1 and 4) , (ii) phosphorylated (Fig.  4) , (iii) recognized by PAb122, which is specific for a carboxylterminal epitope (Fig. 1G) , (iv) associated with ribosomes after a pulse-chase experiment (Fig. 1G) , and (v) covalently linked to 5.8S rRNA ( Fig. 4D and F) . We have previously shown that this linkage is to the penultimate amino acid (serine) of p53 polypeptide (47, 48) .
Binding of p53 polypeptide to ribosomes was shown (i) by cosedimentation of cytoplasmic p53 polypeptide with ribosomes ( Fig. 1 ) and (ii) by specific coprecipitation of rRNAs upon immunoprecipitation of p53 polypeptide (Fig. 4G) . The distribution across the gradient of wt p53 polypeptide from REF and MCF7 cells did not correspond precisely with the OD 254 profile of bulk ribosomes (Fig. 1A to D) . Wild-type p53 polypeptide from REF was predominantly associated with small polysomes. Association of p53 polypeptide with approximately 4% or less of rRNA and with p53 mRNA but not GAPDH mRNA would be consistent with the observed different sedimentation profiles of the p53-associated subset of ribosomes and bulk ribosomes. While wt p53 polypeptide from REF was entirely associated with ribosomes ( Fig. 1A and B) , wt p53 polypeptide from MCF7 cells and A135V mutant p53 polypeptide were found partially or principally at the top of the gradient, not associated with ribosomes ( Fig. 1E to G ). This could have been due to either (i) decreased affinity of the mutant polypeptide for the ribosome; (ii) the fact that overexpressed mutant p53 polypeptide would be in excess of its binding sites; or (iii) the fact that a smaller proportion of mutant p53 polypeptide than wt p53 polypeptide is linked to 5.8S rRNA, and the linkage may be necessary for binding to the ribosomes. It is not clear why cells expressing wt p53 can have various proportions of cytoplasmic p53 polypeptide associated with ribosomes. This might, for instance, depend on cell growth. Treatments with agents which are known to affect the integrity of the ribosomes, (i) puromycin in the presence of high salt and (ii) RNase A, were shown to decrease the sedimentation rate of the vast majority of the wt and mutant p53 polypeptide, which cosedimented with ribosomes and polysomes, indicating association of cytoplasmic p53 polypeptide with the translation machinery. The RNase effect on the sedimentation of p53 polypeptide ( Fig. 2 and 4B ) would be consistent with the possibility either that p53 is bound to the ribosomes, at least in part, through hydrogen bonding between p53-linked 5.8S rRNA and 28S rRNA or that the RNase disrupted ribosomal structure to which p53 was bound.
Cytoplasmic p53 polypeptide is associated with rRNAs. Immunoprecipitation of overexpressed A135V mutant p53 polypeptide specifically coprecipitated 18S and 28S rRNAs (Fig. 4H ). p53-associated ribosomes were, however, only a small subset of total ribosomes, because after serial immunoprecipitation, no more than 4% of total rRNA was immunoprecipitated. This p53 polypeptide-associated subset had another striking peculiarity. 5.8S rRNA could be observed in these ribosomes only after proteolysis by proteinase K (Fig. 4  to F) . This finding indicated not only that all of the 5.8S rRNA in the p53-associated polysomes was covalently linked to protein but also that the 5.8S rRNA in each ribosome in a p53-bound polysome was covalently linked to protein. In marked contrast, 5.8S rRNA was easily extracted from unfractionated ribosomes without proteolysis (Fig. 4H) . Because we have previously reported covalent linkage of p53 polypeptide to 5.8S rRNA and because we were able to prepare 5.8S rRNA from p53 polypeptide bands obtained after immunoprecipitation of sucrose gradient fractions and SDS-PAGE (15), we infer that all of the 5.8S rRNA in the p53-polypeptide-associated ribosomes must be cleaved from p53 polypeptide before it can be extracted in the aqueous phase upon treatment with phenolchloroform and then observed in an RNA gel. These experiments also show that the majority, if not all, of the cytoplasmic p53 which is covalently linked to 5.8S rRNA is associated with ribosomes, arguing that covalent linkage to 5.8S rRNA may be necessary for binding to the ribosome. Although it is clear that all of the 5.8S rRNA in this ribosomal fraction is covalently linked to protein, conversely it is not clear how much of the p53 polypeptide bound to ribosomes is covalently linked to 5.8S rRNA (Fig. 4) . For instance, in X174 A protein complexes linked covalently to X174 DNA, only one monomer of the X174 A protein multimer is covalently linked to the DNA (23) . Purified p53 polypeptide sediments as an 8S tetramer (8, 16, 44) . Consequently, several alternative models of its association with ribosomes could be proposed. For instance, it could bind to ribosomes either as a tetramer with one monomer linked to 5.8S rRNA or as a linked monomer. In summary, these results indicate that the p53 polypeptide is associated with a fraction of ribosomes, at least in part, by its covalent linkage to 5.8S rRNA. Association of p53 polypeptide with a small fraction of ribosomes in growing cells suggested involvement of p53 polypeptide in translational control of a small fraction of mRNA. We suspected that this subset of mRNA might include p53 mRNA. This was because mutant p53 polypeptide is overexpressed and cannot be further induced by DNA damage (17, 25) , suggesting negative autoregulation by wt p53 polypeptide acting in trans. Furthermore, p53 mRNA has a long, structurally encumbered 5Ј UTR (4, 5), suggesting regulation in cis. We found that p53 mRNA was specifically coimmunoprecipitated with p53 polypeptide from cytoplasmic extracts of clone 2 cells, while in contrast, GAPDH mRNA was not coprecipitated. This finding indicates either that p53 polypeptide binds directly to p53 mRNA or that it binds indirectly through binding to ribosomes specifically associated with p53 mRNA, although we have no data at this point indicating that the p53 polypeptide bound to p53 mRNA is the p53 bound to ribosomes. This result may be related to the observation that p53 polypeptide can inhibit the translation of p53 mRNA in a rabbit reticulocyte lysate cell-free translation system, presumably through binding to the 5Ј UTR of p53 mRNA (39) . Hsp70 and GCN4, which are also stress response genes, are regulated translationally dependent on the 5Ј UTRs of their mRNAs (27, 35) . Furthermore, control at the level of translational elongation has also been shown for stress proteins such as Hsp70 (22) . While p53 polypeptide has a carboxy-terminal nucleic acid FIG. 5 . Coimmunoprecipitation of p53 mRNA with p53 polypeptide. Cytoplasmic extracts (nonradiolabeled) of clone 2 cells were serially immunoprecipitated; i.e., the extract was immunoprecipitated with PAb248-protein A-Sepharose (lane 1), the supernatant was reprecipitated (lane 2), and that supernatant was reimmunoprecipitated a third time (lane 3). RNA was then prepared from each immunoprecipitate and from the final supernatant (lane S). The RNA was then resolved in a 1% agarose gel in formamide. The RNA was transferred to a nylon membrane and hybridized to a 32 P-labeled cDNA probe against p53, the EcoRV-StuI fragment containing only p53-coding sequences (A). (B) The same filter was stripped and then rehybridized with a probe against GAPDH.
binding domain (residues 364 to 390 in the murine p53 polypeptide) (42, 58) distinct from (i) the DNA binding domain (2, 7, 44, 57) , and (ii) the 5.8S rRNA covalent linkage site (15, 48) , and this site binds RNA with higher affinity than DNA (42) , the binding specificity of this carboxy-terminal site has not been established. Also, Ewen et al. (13) have reported that translational repression of CDK4 by transforming growth factor ␤1 is mediated by p53. This activity may be either direct or indirect. If this activity of p53 is direct, it may suggest that CDK4 mRNA will be found associated with p53 polypeptide. It should also be mentioned that p53 polypeptide is not the first growth-regulatory protein found to be associated with translation. The bona fide translational regulatory proteins eIF-4E and p68 DAI kinase are postulated to be an oncogene and a tumor suppressor, respectively (1, 10, 26, 37) .
Our finding that the 5.8S rRNA in p53 polypeptide-associated ribosomes is covalently linked to protein suggests that these ribosomes have altered activity. 5.8S rRNA is a nuclear cleavage product of the Ͼ45S rRNA transcript. It is transcribed from multicopy rRNA genes in a cell cycle-dependent manner, and it is an essential constituent of the ribosome. 5.8S rRNA forms hydrogen bonds with 28S rRNA in both the nuclear ribosomal precursor and the cytoplasmic 60S ribosomal subunit (45) . However, 5.8S rRNA also binds the S9 and S13 proteins of the 40S ribosomal subunit (55) , suggesting that 5.8S rRNA is near the ribosomal subunit interface and leading to the hypothesis that it is part of the ribosomal A site. 5.8S rRNA antisense oligodeoxyribonucleotides inhibit protein synthesis (56) . This localization of 5.8S rRNA within the ribosome suggests that the covalent linkage of p53 polypeptide to 5.8S rRNA could alter translational initiation and/or elongation. Currently, we are testing a model whereby the p53-5.8S rRNA covalent complex would be formed by the nucleolytic attack of p53 polypeptide upon the Ͼ45S rRNA precursor, resulting in the incorporation of p53 polypeptide into the maturing 60S ribosomal subunit.
